Prachi Bhave

Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma

James R. Patrinely, Rebecca Johnson, Aleigha Lawless et al. · JAMA Oncology · 2021 · 235 citations · Full text

Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma

C. Owen, Xue Bai, Serigne Lo et al. · Annals of Oncology · 2021 · 172 citations · Full text

Tumor Immunology, Melanoma, Immunology +6

Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders

Lauren Brown, Alison M. Weppler, Prachi Bhave et al. · Journal for ImmunoTherapy of Cancer · 2021 · 88 citations · Full text

Immunodeficiencies, Immunology, Immunoediting +25

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy

Briana R. Halle, Allison Betof Warner, Farzana Y. Zaman et al. · Journal for ImmunoTherapy of Cancer · 2021 · 62 citations · Full text

Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis

Prachi Bhave, Lalit Pallan, Georgina V. Long et al. · British Journal of Cancer · 2020 · 61 citations · Full text